The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
MamaPred: A new and innovative approach to determine recurrence risk in HR+/HER2- early-stage breast cancer using HTG EdgeSeq technology.
 
Jose Antonio Lopez Guerrero
Consulting or Advisory Role - AstraZeneca
Speakers' Bureau - AstraZeneca Spain; MSD; SOPHiA Genetics
Research Funding - AstraZeneca Spain (Inst); HTG Molecular Diagnostics (Inst)
 
Carlos Loucera
No Relationships to Disclose
 
Marta Ramírez-Calvo
No Relationships to Disclose
 
María Peña
No Relationships to Disclose
 
Antonio Fernandez-Serra
No Relationships to Disclose
 
Angel Guerrero-Zotano
Consulting or Advisory Role - AstraZeneca; Novartis
Speakers' Bureau - AstraZeneca; Novartis; Pfizer; Roche
Research Funding - Pfizer (Inst)
Travel, Accommodations, Expenses - Novartis; Pfizer; Roche
 
José Palacios
No Relationships to Disclose
 
Octavio Burgues
Honoraria - Roche
Travel, Accommodations, Expenses - Roche
 
Sonia Servitja
Speakers' Bureau - Eisai; MSD; Roche
 
Ignacio Tusquets
Travel, Accommodations, Expenses - Roche
 
Gloria Peiro
No Relationships to Disclose
 
Begoña Bermejo
Consulting or Advisory Role - MSD; Novartis; Roche
Speakers' Bureau - MSD; Novartis; Pfizer; Roche
Travel, Accommodations, Expenses - Pfizer
 
Joan Albanell
Consulting or Advisory Role - Amgen; Daiichi Sankyo; Genomic Health; Lilly; Novartis; Pfizer; Roche; Seagen
Research Funding - Amgen (Inst); Daiichi Sankyo (Inst); Pfizer (Inst); Roche (Inst); Seagen (Inst)
Patents, Royalties, Other Intellectual Property - Biocartis (Inst)
Travel, Accommodations, Expenses - Amgen; Pfizer; Roche
 
Antonio Llombart-Cussac
Stock and Other Ownership Interests - MedSIR
Consulting or Advisory Role - Agendia; Daiichi Sankyo; Eisai; Lilly; Novartis; Pfizer; Pierre Fabre; Roche; Seagen
Research Funding - Agendia (Inst); Eisai (Inst); Genomic Health (Inst); GlaxoSmithKline (Inst); Lilly (Inst); Novartis (Inst); Pfizer (Inst); Roche (Inst)
Travel, Accommodations, Expenses - Lilly; Pfizer; Roche
 
Joaquin Dopazo
Research Funding - AstraZeneca (Inst)